EU Clears Agilent Acquisition of Varian; Product Lines to be Divested | GenomeWeb

NEW YORK (GenomeWeb News) – European Union regulatory authorities have granted antitrust clearance of Agilent's proposed acquisition of Varian, with conditions that include the sale of certain product lines.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.